✦ LIBER ✦

Tipifarnib active in poor-risk acute myeloid leukaemia

Book ID: 120848183
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715800-00033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clofarabine in the treatment of poor ris

Clofarabine in the treatment of poor risk acute myeloid leukaemia

✍ Janusz Krawczyk; Naeem Ansar; Ronan Swords; Tracy Murphy; Barry MacDonagh; Teres 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract Clofarabine is a second generation nucleoside analogue. It inhibits DNA repair and activates the mitochondrial apoptotic pathway leading to cell death. __In vitro__ clofarabine has demonstrated synergy with daunorubicin and Ara‐C and in phase II clinical trials has shown promising activ

Proceedings: Active immunotherapy in acu

Proceedings: Active immunotherapy in acute myeloid leukaemia

✍ Freeman, C B; Taylor, G M; Harris, R; Geary, C G; MacIver, J E; Delamore, I W 📂 Article 📅 1975 🏛 Nature Publishing Group 🌐 English ⚖ 336 KB

Karyotypically defined risk groups in ac

Karyotypically defined risk groups in acute myeloid leukaemia

✍ A.K. Burnett 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Aberrant expression of MIR9 indicates po

Aberrant expression of MIR9 indicates poor prognosis in acute myeloid leukaemia

✍ Kazuhiro Maki; Tetsuya Yamagata; Fusako Sugita; Yuka Nakamura; Ko Sasaki; Kinuko 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Cytogenetics in acute myeloid leukaemia

✍ H Walker; F.J Smith; D.R Betts 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 985 KB

Acute myeloid leukaemia in children

✍ Peter B. Langmuir; Richard Aplenc; Beverly J. Lange 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 162 KB